Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management-Reference-Cited by-同舟云学术

Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management

Published:2021-11-23 Issue:1 Volume:12 Page:29-40
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Musiek Amy C. M.,Rieger Kerri E.,Bagot Martine,Choi Jennifer N.,Fisher David C.,Guitart Joan,Haun Paul L.,Horwitz Steven M.,Huen Auris Onn-Lay,Kwong Bernice Y.,Lacouture Mario E.,Noor Sarah J.,Rook Alain H.,Seminario-Vidal Lucia,Vermeer Maarten H.,Kim Youn H.

Funder

Kyowa Kirin, Inc.

NIH/NCI Cancer Center Support Grant

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

https://link.springer.com/content/pdf/10.1007/s13555-021-00624-7.pdf

Reference41 articles.

1. Teras LR, DeSantis CE, Cerhan JR, et al. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016;66:443–59.

2. Olsen EA, Whittaker S, Kim YH, et al. Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011;29:2598–607.

3. Foss FM, Girardi M. Mycosis fungoides and Sézary syndrome. Hematol Oncol Clin North Am. 2017;31:297–315.

4. Bhat TS, Herbosa CM, Rosenberg AR, et al. Current measures are not sufficient: an interview-based qualitative assessment of quality of life in cutaneous T-cell lymphoma. Br J Dermatol. 2021;184:310–8.

5. Semenov YR, Rosenberg AR, Herbosa C, Mehta-Shah N, Musiek AC. Health-related quality of life and economic implications of cutaneous T-cell lymphoma. Br J Dermatol. 2020;182:190–6.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mogamulizumab and Concomitant Hypofractionated Low-Dose Total Skin Electron Beam Therapy (2 × 4 Gy) in Cutaneous T-Cell Lymphoma: Proof of Principle, Report of Two Cases;Current Oncology;2024-09-13

2. A case of mogamulizumab‐induced vitiligo in a patient with mycosis fungoides;JEADV Clinical Practice;2024-08-19

3. Mogamulizumab‐assoziierter Rash – Fallserie und aktuelle Literatur;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-08

4. Mogamulizumab‐associated rash – Case series and review of the literature;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-06-25

5. Arzneimittelexantheme unter Immun- und zielgerichteter onkologischer Therapie;Die Dermatologie;2024-05-21